Apogee Therapeutics, Inc. APGE Net Income
Net Income at other companies
Segments
By segment
See fullOther financials
Where this comes from
Reported directly by Apogee Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ProfitLoss.
The official record: Apogee Therapeutics, Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Apogee Therapeutics, Inc.'s net income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Apogee Therapeutics, Inc.'s net income?
- Apogee Therapeutics, Inc. (APGE) reported net income of -$74.11M in Q1 2026.
- How has Apogee Therapeutics, Inc.'s net income changed year-over-year?
- Apogee Therapeutics, Inc.'s net income decreased by 33.9% year-over-year, from -$55.34M to -$74.11M.
- What is the long-term trend for Apogee Therapeutics, Inc.'s net income?
- Over 3 years (2022 to 2025), Apogee Therapeutics, Inc.'s net income has grown at a 49.9% compound annual growth rate (CAGR), from -$75.99M to -$255.84M.
- What does net income mean?
- Net income as the starting point for the indirect method operating cash flow reconciliation.